Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes ...

In older adults with diabetes, GLP-1 receptor agonists ... molecular structure of GLP-1 agonist agent (semaglutide [Ozempic], ...

For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased risk for psychiatric adverse events or worsening ...

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights ...

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...

GLP-1 receptor agonists may aid smoking cessation by curbing cravings and mitigating weight gain, which often are impediments in quitting, according to a presentation at the American Psychiatric ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a group of drugs used ... For example, research has shown that treatment with Ozempic, Trulicity, Rybelsus, or Victoza is linked to ...

There is also a similar medication called tirzepatide (Mounjaro/Zepbound), which is a dual GLP-1/GIP receptor agonist. This means it works on GLP-1, as well as another receptor called glucose ...

Seven different GLP-1 receptor agonists were investigated among the trials, including semaglutide (also known as Ozempic or Wegovy), dulaglutide (Trulicity) and liraglutide (Victoza). The results ...

GLP-1 receptor agonists also were associated with a 48 ... (Victoza), lixisenatide (now discontinued), dulaglutide (Trulicity), and semaglutide (Ozempic). DPP-4 inhibitors included the agents ...

A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due to study variability and patient differences. Review ...

GLP-1 receptor agonists promote the feeling of fullness before eating via neurons in the dorsomedial hypothalamus, according to a new study. The findings offer new insights into the neural ...